While whole exome sequencing has identified mutations of FANCM as a high risk factor for ovarian and breast cancers [104, 105], and another study has demonstrated increased cancer risk and chemotherapy toxicity in individuals with FANCM mutations [106], mutations appear to be less pathogenic than those in the other FA proteins [107]. Here, FANCM is linked to cancer.